117 related articles for article (PubMed ID: 26703840)
1. H274Y's Effect on Oseltamivir Resistance: What Happens Before the Drug Enters the Binding Site.
Yusuf M; Mohamed N; Mohamad S; Janezic D; Damodaran KV; Wahab HA
J Chem Inf Model; 2016 Jan; 56(1):82-100. PubMed ID: 26703840
[TBL] [Abstract][Full Text] [Related]
2. Infiltration of water molecules into the oseltamivir-binding site of H274Y neuraminidase mutant causes resistance to oseltamivir.
Park JW; Jo WH
J Chem Inf Model; 2009 Dec; 49(12):2735-41. PubMed ID: 19957991
[TBL] [Abstract][Full Text] [Related]
3. Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses.
Singh A; Soliman ME
Drug Des Devel Ther; 2015; 9():4137-54. PubMed ID: 26257512
[TBL] [Abstract][Full Text] [Related]
4. Mutation-induced loop opening and energetics for binding of tamiflu to influenza N8 neuraminidase.
Kar P; Knecht V
J Phys Chem B; 2012 May; 116(21):6137-49. PubMed ID: 22553951
[TBL] [Abstract][Full Text] [Related]
5. Comment on "Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV)".
Rungrotmongkol T; Malaisree M; Udommaneethanakit T; Hannongbua S
Biophys Chem; 2009 Apr; 141(1):131-2; author reply 133. PubMed ID: 19231807
[No Abstract] [Full Text] [Related]
6. Source of oseltamivir resistance in avian influenza H5N1 virus with the H274Y mutation.
Malaisree M; Rungrotmongkol T; Nunthaboot N; Aruksakunwong O; Intharathep P; Decha P; Sompornpisut P; Hannongbua S
Amino Acids; 2009 Oct; 37(4):725-32. PubMed ID: 19002747
[TBL] [Abstract][Full Text] [Related]
7. Understanding of known drug-target interactions in the catalytic pocket of neuraminidase subtype N1.
Malaisree M; Rungrotmongkol T; Decha P; Intharathep P; Aruksakunwong O; Hannongbua S
Proteins; 2008 Jun; 71(4):1908-18. PubMed ID: 18175324
[TBL] [Abstract][Full Text] [Related]
8. Comment on 'Comment on "Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV)"'.
Mitrasinovic PM
Biophys Chem; 2011 Mar; 154(2-3):102. PubMed ID: 21316835
[No Abstract] [Full Text] [Related]
9. The inhibitory performance of flavonoid cyanidin-3-sambubiocide against H274Y mutation in H1N1 influenza virus.
Kannan S; Kolandaivel P
J Biomol Struct Dyn; 2018 Dec; 36(16):4255-4269. PubMed ID: 29199545
[TBL] [Abstract][Full Text] [Related]
10. Insights into susceptibility of antiviral drugs against the E119G mutant of 2009 influenza A (H1N1) neuraminidase by molecular dynamics simulations and free energy calculations.
Pan P; Li L; Li Y; Li D; Hou T
Antiviral Res; 2013 Nov; 100(2):356-64. PubMed ID: 24055835
[TBL] [Abstract][Full Text] [Related]
11. Insight into the oseltamivir resistance R292K mutation in H5N1 influenza virus: a molecular docking and molecular dynamics approach.
Karthick V; Ramanathan K
Cell Biochem Biophys; 2014 Mar; 68(2):291-9. PubMed ID: 23794010
[TBL] [Abstract][Full Text] [Related]
12. Computational studies of H5N1 influenza virus resistance to oseltamivir.
Wang NX; Zheng JJ
Protein Sci; 2009 Apr; 18(4):707-15. PubMed ID: 19309695
[TBL] [Abstract][Full Text] [Related]
13. Theoretical studies on the susceptibility of oseltamivir against variants of 2009 A/H1N1 influenza neuraminidase.
Li L; Li Y; Zhang L; Hou T
J Chem Inf Model; 2012 Oct; 52(10):2715-29. PubMed ID: 22998323
[TBL] [Abstract][Full Text] [Related]
14. Dynamic behavior of avian influenza A virus neuraminidase subtype H5N1 in complex with oseltamivir, zanamivir, peramivir, and their phosphonate analogues.
Udommaneethanakit T; Rungrotmongkol T; Bren U; Frecer V; Stanislav M
J Chem Inf Model; 2009 Oct; 49(10):2323-32. PubMed ID: 19780597
[TBL] [Abstract][Full Text] [Related]
15. Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.
Yen HL; Ilyushina NA; Salomon R; Hoffmann E; Webster RG; Govorkova EA
J Virol; 2007 Nov; 81(22):12418-26. PubMed ID: 17855542
[TBL] [Abstract][Full Text] [Related]
16. Neuraminidase mutations conferring resistance to laninamivir lead to faster drug binding and dissociation.
McKimm-Breschkin JL; Barrett S
Antiviral Res; 2015 Feb; 114():62-6. PubMed ID: 25499124
[TBL] [Abstract][Full Text] [Related]
17. Long time scale GPU dynamics reveal the mechanism of drug resistance of the dual mutant I223R/H275Y neuraminidase from H1N1-2009 influenza virus.
Woods CJ; Malaisree M; Pattarapongdilok N; Sompornpisut P; Hannongbua S; Mulholland AJ
Biochemistry; 2012 May; 51(21):4364-75. PubMed ID: 22574858
[TBL] [Abstract][Full Text] [Related]
18. Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV).
Mihajlovic ML; Mitrasinovic PM
Biophys Chem; 2008 Aug; 136(2-3):152-8. PubMed ID: 18584938
[TBL] [Abstract][Full Text] [Related]
19. Molecular dynamics simulation of oseltamivir resistance in neuraminidase of avian influenza H5N1 virus.
Shu M; Lin Z; Zhang Y; Wu Y; Mei H; Jiang Y
J Mol Model; 2011 Mar; 17(3):587-92. PubMed ID: 20517627
[TBL] [Abstract][Full Text] [Related]
20. Exploring the cause of oseltamivir resistance against mutant H274Y neuraminidase by molecular simulation approach.
Karthick V; Shanthi V; Rajasekaran R; Ramanathan K
Appl Biochem Biotechnol; 2012 May; 167(2):237-49. PubMed ID: 22544690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
